Pfizer Padcev — Revenues: increased by 16.3% to $591.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.7%, from $426.00M to $591.00M.
pfe_segment_padcev_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $53.00M | $341.00M | $394.00M | $409.00M | $444.00M | $426.00M | $542.00M | $464.00M | $508.00M | $591.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | +543.4% | +15.5% | +3.8% | +8.6% | -4.1% | +27.2% | -14.4% | +9.5% | +16.3% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +737.7% | +24.9% | +37.6% | +13.4% | +14.4% | +38.7% |